...
首页> 外文期刊>Journal of Pathology: Journal of the Pathological Society of Great Britain and Ireland >Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low- and high-grade types.
【24h】

Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low- and high-grade types.

机译:B细胞非霍奇金淋巴瘤中的爱泼斯坦-巴尔病毒:低级和高级别类型的意外感染模式和不同感染率。

获取原文
获取原文并翻译 | 示例
           

摘要

Two hundred and eight cases of B-cell non-Hodgkin's lymphoma (B-NHL) occurring in Europeans without any signs of HIV infection were investigated for their association with an Epstein-Barr virus (EBV) infection. The polymerase chain reaction (PCR) was applied for EBV-DNA detection, in situ hybridization (ISH) for the cellular localization of EBV-encoded small nuclear RNAs (EBER) and immediate-early RNAs (BHLF), and immunohistology (IH) for the detection of EBV-encoded latent membrane protein (LMP) and EBV nuclear antigen 2 (EBNA2) expression. PCR and EBER-ISH produced congruent results in those cases with amplifiable DNA. EBV was present overall in 26 per cent (54/208) of the B-NHL cases. Through EBER-ISH, the virus could be localized merely in rare non-neoplastic bystander lymphocytes in 27 and additionally in tumour cells of 27 cases. Unexpectedly, the proportion of EBV-infected tumour cells present in the different cases varied between 1 and 100 per cent. All but three of the cases with infected tumour cells were of high-grade malignancy. Correlation with the morphological and immunological tumour phenotype revealed that all cases with more than 80 per cent EBER-positive tumour cells were either B-anaplastic large cell lymphomas (B-ALCL), sporadic Burkitt's lymphomas, or B-NHLs with partial or full plasmacellular differentiation. LMP was consistently absent from Burkitt's lymphomas and constantly expressed in B-ALCLs with EBER-positive tumour cells, while in all other instances it varied greatly and was rarer than EBER expression.(ABSTRACT TRUNCATED AT 250 WORDS)
机译:调查了欧洲人中无HIV感染迹象的B例非霍奇金淋巴瘤(B-NHL)288例与爱泼斯坦-巴尔病毒(EBV)感染的关系。聚合酶链反应(PCR)用于EBV-DNA检测,原位杂交(ISH)用于EBV编码的小核RNA(EBER)和立即早期RNA(BHLF)的细胞定位,以及免疫组织学(IH)用于检测EBV编码的潜伏膜蛋白(LMP)和EBV核抗原2(EBNA2)的表达。在那些带有可扩增DNA的情况下,PCR和EBER-ISH产生了一致的结果。 EBV在B-NHL病例中占26%(54/208)。通过EBER-ISH,该病毒仅可以定位在27例罕见的非肿瘤旁观者淋巴细胞中,还可以定位在27例肿瘤细胞中。出乎意料的是,在不同病例中,被EBV感染的肿瘤细胞的比例在1%至100%之间变化。除三例感染肿瘤细胞的病例外,其余均为恶性肿瘤。与形态学和免疫学肿瘤表型的相关性表明,所有EBER阳性肿瘤细胞超过80%的病例均为B-间变性大细胞淋巴瘤(B-ALCL),散发性Burkitt淋巴瘤或部分或全部浆细胞的B-NHL差异化。 LMP在Burkitt淋巴瘤中始终不存在,并且在具有EBER阳性肿瘤细胞的B-ALCL中持续表达,而在所有其他情况下,LMP差异很大且比EBER表达少(摘要以250字截短)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号